Products
Online Inquiry
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
Teriparatide Acetate
Cat No.
CEPP-003
Description
Teriparatide is a synthetic peptide composed of the first 34 amino acids of human parathyroid hormone (PTH), which has 84 amino acids in total. This fragment represents the biologically active N-terminal region of endogenous PTH. Teriparatide mediates bone metabolism through multiple mechanisms.
Inhibition of Osteoblast Apoptosis:
Teriparatide reduces the apoptosis of osteoblasts, thereby increasing their survival time and promoting bone formation.
Activation of Lining Cells and Enhancement of Osteoblast Differentiation:
Teriparatide regulates the adenylyl cyclase-cAMP-protein kinase A signaling pathway to intermittently stimulate PTH-Ⅰ receptors on the surface of osteoblasts, lining cells, and bone marrow stromal stem cells. This stimulation promotes the differentiation of osteoblasts and extends their lifespan.
Through the phosphatidylinositol phosphate-C-intracellular calcium-protein kinase C signaling pathway, teriparatide stimulates the proliferation of osteoblast cell lines.
Teriparatide also inhibits the transactivation activity of PPARγ, reducing the differentiation of stromal cells into adipocytes, thereby increasing the number of osteoblasts.
Regulation of Cytokines:
Teriparatide induces the binding of IGF-1 to osteoblasts, promoting bone formation.
It regulates the bone formation process through the Wnt signaling pathway, thereby increasing bone formation.
Inhibition of Osteoblast Apoptosis:
Teriparatide reduces the apoptosis of osteoblasts, thereby increasing their survival time and promoting bone formation.
Activation of Lining Cells and Enhancement of Osteoblast Differentiation:
Teriparatide regulates the adenylyl cyclase-cAMP-protein kinase A signaling pathway to intermittently stimulate PTH-Ⅰ receptors on the surface of osteoblasts, lining cells, and bone marrow stromal stem cells. This stimulation promotes the differentiation of osteoblasts and extends their lifespan.
Through the phosphatidylinositol phosphate-C-intracellular calcium-protein kinase C signaling pathway, teriparatide stimulates the proliferation of osteoblast cell lines.
Teriparatide also inhibits the transactivation activity of PPARγ, reducing the differentiation of stromal cells into adipocytes, thereby increasing the number of osteoblasts.
Regulation of Cytokines:
Teriparatide induces the binding of IGF-1 to osteoblasts, promoting bone formation.
It regulates the bone formation process through the Wnt signaling pathway, thereby increasing bone formation.
Applications
For use in osteoporosis. Treatment of osteoporosis in menopausal women and also in male patients with primary or hypogonadal osteoporosis.
Package
1G/Bottle, 10G/Bottle, 50G/Bottle or at customers reqirement.
CAS No.
52232-67-4
Molecular Weight
4117.72 g/mol
Purity
98%
Storage
2~8°C
Molecular Formula
C181H291N55O51S2
Amino Acid Sequence
H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
Download
Download Datasheet